Together, these findings suggest that common polymorphisms in the ASVD risk interval could modulate ANRIL transcription and/or splicing, thereby influencing PcG-mediated INK4/ARF repression and atherosclerosis susceptibility. The gene discussed is CDKN2A; the disease is atherosclerosis.